Background and aims Hyperbaric 2% prilocaine (HP) is increasingly used for spinal anesthesia in the ambulatory setting. Therefore, there is a need to understand this local anesthetic in terms of administration, efficiency and side effects. In this context, we conducted an observational study on a large panel of patients scheduled for day-case surgery.
Methods This retrospective study was approved by the local Medical Ethics Committee. Data (dose of HP, success-failure, time of discharge, EVA (0–10), side effects, satisfaction graded from 0 to 10) were collected based on the electronic patient file. Intrathecal HP was compared to the association HP-sufentanil by using a propensity score after matching groups on the following confounding variables: gender, age, weight, size, BMI, ASA score, type of surgery, posology of HP, analgesics, midazolam.
Results Data from 794 patients, ASA-score I to III, 50.44±13.66 years-old were analyzed. Prilocaine was injected solely in 76% of the cases at the dose of 50.25±10.17 mg. Surgery was possible in 90.06% under spinal anesthesia only. Failures were not related to age, size, weight, BMI or intrathecal sufentanil. The time of discharge was decreased by the administration of intrathecal sufentanil (457.02±75.76 vs 487.02±83.52 min, p<0.001). Bradycardia and hypotension were observed in 10.05% and 10.23%, respectively, and not modified by intrathecal sufentanil. Five cases of urinary retention and one case of transient neurologic symptom were recorded. Satisfaction of the patients was 8.51±1.87.
Conclusions Intrathecal HP is efficient and side effects are rare. Sufentanil as an adjuvant is able to decrease the time of discharge.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.